Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rie S. Bech
Real World Data on Rituximab Maintenance Therapy After Frontline Immunochemotherapy in Grade 1-3a Follicular Lymphoma
British Journal of Haematology
Hematology
Related publications
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
OUTCOMES AFTER EARLY TRANSFORMATION (tPOD24) VS. EARLY FOLLICULAR LYMPHOMA PROGRESSION (fPOD24) IN FOLLICULAR LYMPHOMA TREATED WITH FRONTLINE IMMUNOCHEMOTHERAPY
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Grade 3a Follicular Lymphoma Can Be Effectively Controlled With Very Low Dose Radiation Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Gene Expression Profiling Reveals a Close Relationship Between Follicular Lymphoma Grade 3A and 3B, but Distinct Profiles of Follicular Lymphoma Grade 1 and 2
Haematologica
Hematology
Real World Data and the Art of Maintenance Therapy
British Journal of Haematology
Hematology
The Comparison of De Novo Grade 3 Follicular Lymphoma and Transformed Grade 3 Follicular Lymphoma: Own Data
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Refractoriness to Immunochemotherapy in Follicular Lymphoma: Predictive Factors and Outcome
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Value of Pre-Treatment Pet Scan in Patients With Follicular Lymphoma Receiving Frontline Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Immunochemotherapy With Obinutuzumab or Rituximab in Previously Untreated Follicular Lymphoma in the Randomised Phase Iii Gallium Study: Analysis by Chemotherapy Regimen
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
